| 词条 | Zoetis |
| 释义 |
| name = Zoetis Inc. | logo = Zoetis logo sw.jpg | type = Public | traded_as = {{ubl|{{NYSE|ZTS}} (Class A)|S&P 500 component}} | foundation = {{Start date|1952}} | industry = Pharmaceutical | location = Parsippany, New Jersey, U.S.[1] | area_served = Worldwide | key_people = Juan Ramon Alaix (CEO) | products = | revenue = {{nowrap|{{increase}} US$5,307 million {{small|(2017)}}}} | operating_income = {{nowrap|{{increase}} US$1,525 million {{small|(2017)}}}} | net_income = {{nowrap|{{increase}} US$864 million {{small|(2017)}}}} | assets = {{nowrap|{{increase}} US$8,586 million {{small|(2017)}}}} | equity = {{nowrap|{{increase}} US$1,770 million {{small|(2017)}}}} | num_employees = 9,200[2] | num_employees_year = 2017 | parent = Pfizer | subsid = | website = {{URL|http://www.zoetis.com/|Zoetis.com}} | footnotes = [3] }}Zoetis Inc. (/zō-EH-tis/[4]) is the world's largest producer of medicine and vaccinations for pets and livestock.[5][4][6] The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets the products in approximately 45 countries, and sells the products in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue.[5] Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.[7] History1950s to 2000sIn the 1950s, Pfizer began research on several drugs including Oxytetracycline.[10] John McKeen, a chemical engineer with Pfizer products, discovered its effective use in livestock. In 1952, the Pfizer Agriculture Division opened a 732-acre research and development facility in Terre Haute, Indiana called Vigo.[8][9] By 1988 the division was renamed Pfizer Animal Health.[8] The acquisition of GlaxoSmithKline’s Norden Laboratories in 1995 boosted Pfizer's animal health division into small animal care including domestic pets.[8] Secondary research and development centres were opened in Kalamazoo, Michigan in 2003.[8] In the same year, Pfizer acquired Pharmacia Corporation for US$ 60 billion in stock options.[10] Between 2007 and 2011 the company acquired Embrex Inc, Catapult Genetics, Bovigen, Wyeth, Fort Dodge Animal Health, Vetnex Animal Health Ltd, Synbiotics Corporation, Microtek, King Pharmaceuticals, and Alpharma.[8] These acquisitions greatly increased Pfizer's market, range of products, countries it operated in, and resources. {{Clear}}2010s to presentPlans to break away Pfizer Animal Health into a separate company were officially announced in 2012.[11][4] The name chosen, Zoetis, roughly translates from the derived Latin zoological word zoetic, meaning 'pertaining to life'.[4] Zoetis Inc.'s revenues exceeded $4.2 billion in 2011 and $4.34 billion in 2012.[12][22][4] The animal health industry worldwide is an estimated US$22 billion dollar industry.[4] On 22 May 2013, The Wall Street Journal reported that Pfizer plans to sell its majority stake in the company.[13] According to the report, shareholders will have the option to swap their Pfizer shares for Zoetis shares.[13] The sell off of Zoetis is consistent with Pfizer's recent decision to shed other non-pharmaceuticals subsidiaries in an effort to save costs, raise capital, and pay off debt. The company has announced that JPMorgan Chase, Bank of America Merrill Lynch, Goldman Sachs & Co., and Morgan Stanley will be the lead underwriters.[14][13] In November 2014, activist investor Bill Ackman disclosed that Pershing Square Capital Management had taken an 8.5% stake in the company, amassing approximately 41.8 million shares, causing the share price to hit its highest price since the IPO.[15] On 17 November, the company announced it would acquire a portfolio of pet drugs from Abbott Laboratories for approximately $255 million.[16] 2012: IPORecords show that Pfizer officially filed for registration of a Class A stock with the U.S. Securities and Exchange Commission on 10 August 2012.[8][17] Zoetis' IPO on 1 February 2013 sold 86.1 million shares for US$ 2.2 billion.[18] Shares sharply rose 19% by the end of the trading day to $35.01 a share, up from $26.[4] At the time, it was the largest IPO from a U.S. company since Facebook's $16 billion IPO on 18 May 2012.[19] Pfizer retained 414 million Class B shares giving it an 83% controlling stake in the firm.[20][1] Stock investors were attracted to the steep profit margin in proportion to revenue and consumer confidence in potential future growth of the subsidiary.[4] The offering's lead underwriters were JPMorgan Chase, Bank of America Merrill Lynch and Morgan Stanley.[18] Most of the money raised through the IPO was used to pay off existing Pfizer debt.[4] AcquisitionsIn November 2015, the company announced it would acquire developer of aquaculture treatments and diseases, Pharmaq, for $765 million.[21][22] In 2017, Zoetis acquired Ireland-based Nexvet, a company with a biologics focused technology and product candidate pipeline.[23] In May 2018, the company announced its intention to acquire Abaxis for $1.9 billion in cash.[24] ProductsTwenty-eight sites in 11 countries make up Zoetis manufacturing network, each facility designed to meet chemical and infectious agent safety regulatory requirements. Many R&D operations are co-located with manufacturing sites, a collaboration that allows bringing new products to market faster. Zoetis builds on six-decade Pfizer history and aims for high tech innovative manufacturing technologies. Zoetis products include:[25] {{div col|colwidth=18em}}
References1. ^1 {{cite news|url=https://www.wsj.com/articles/SB10001424127887323701904578276530830057770 |title=Zoetis Raises $2.2 Billion in IPO - WSJ.com|last=DIETERICH|first=CHRIS|date=31 January 2013|work=The Wall Street Journal|accessdate=1 February 2013|location=New York}} 2. ^{{Cite web|url=http://fortune.com/fortune500/zoetis/|title=Zoetis|website=Fortune|access-date=2019-01-07}} 3. ^{{cite web|url=https://www.sec.gov/Archives/edgar/data/1555280/000155528018000053/zoetis-20171231x10kye.htm |title=Zoetis Inc. 2017 Annual Report Form (10-K) |publisher=U.S. Securities and Exchange Commission |date=February 15, 2018 |accessdate=September 29, 2018}} 4. ^1 2 3 4 5 6 7 8 {{cite news|url=http://www.cbsnews.com/8301-34227_162-57567222/shares-of-animal-health-company-zoetis-soar-in-ipo/|title=Shares of animal health company Zoetis soar in IPO|date=1 February 2013|work=CBS News|accessdate=1 February 2013|location=New York}} 5. ^1 {{cite web|url=http://pdf.secdatabase.com/2372/0001555280-18-000053.pdf |title=Zoetis Inc, Form 10-K, Annual Report, Filing Date Feb 15, 2018 |publisher=secdatabase.com |accessdate =Apr 26, 2018}} 6. ^{{cite news|url=https://finance.yahoo.com/news/zoetis-raises-2-2-billion-124704383.html|title=Zoetis raises about $2.2 billion in IPO|date=1 February 2013|work=The Associated Press|publisher=Yahoo!|accessdate=1 February 2013|location=New York}} 7. ^Zoetis to join S&P 500 8. ^1 2 3 4 5 6 {{cite web|url=https://www.sec.gov/Archives/edgar/data/1555280/000119312512350448/d381653ds1.htm|title=Form S-1|date=10 August 2012|publisher=U.S. Securities and Exchange Commission|accessdate=2 February 2013|location=WASHINGTON, D.C}} 9. ^{{cite news|url=https://pqasb.pqarchiver.com/chicagotribune/access/568975732.html?dids=568975732:568975732&FMT=CITE&FMTS=CITE:AI&type=historic&date=Jul+17%2C+1958&author=&pub=Chicago+Tribune&desc=Pfizer+Buys+732+Acre+Vigo+Chemical+Plant&pqatl=google|title=Pfizer Buys 732 Acre Vigo Chemical Plant|date=17 Jul 1958|work=Chicago Daily Tribune|page=1|accessdate=2 February 2013}} 10. ^{{cite news|url=https://www.wsj.com/articles/SB1026684057282753560|title=Pfizer to Buy Pharmacia For $60 Billion in Stock|date=15 July 2002|work=The Wall Street Journal|accessdate=2 February 2013|first1=Robert|last1=Frank|first2=Scott|last2=Hensley}} 11. ^{{cite web|url=http://edgar.secdatabase.com/2046/119312512420207/filing-main.htm |title=Zoetis Inc, Form S-1/A, Filing Date Oct 11, 2012 |publisher=secdatabase.com |accessdate =Apr 26, 2018}} 12. ^{{cite web|url=http://pdf.secdatabase.com/1660/0001555280-13-000008.pdf |title=Zoetis Inc, Form 10-K, Annual Report, Filing Date Mar 28, 2013 |publisher=secdatabase.com |accessdate =Apr 26, 2018}} 13. ^1 2 3 {{cite news|url=https://www.wsj.com/articles/SB10001424127887323975004578498994013821124|title=Pfizer to Spin Off Remaining Zoetis Stake|last=Loftus|first=Peter|date=22 May 2013|work=The Wall Street Journal|accessdate=27 May 2013}} 14. ^{{cite web|url=http://pdf.secdatabase.com/2788/0001193125-13-233678.pdf |title=Zoetis Inc, Form 425, Filing Date May 23, 2013 |publisher=secdatabase.com |accessdate =Apr 26, 2018}} 15. ^{{cite news| url=https://www.bloomberg.com/news/2014-11-11/ackman-s-pershing-square-takes-stake-in-animal-drugmaker-zoetis.html | work=Bloomberg | first=Caroline | last=Chen | title=Ackman's Pershing Square Takes Stake in Drugmaker Zoetis | date=11 November 2014}} 16. ^{{cite web|url=http://edgar.secdatabase.com/326/155528014000340/filing-main.htm |title=Zoetis Inc, Form 8-K, Current Report, Filing Date Nov 17, 2014 |publisher=secdatabase.com |accessdate =Apr 26, 2018}} 17. ^{{cite web|url=http://edgar.secdatabase.com/67/119312513027025/filing-main.htm |title=Zoetis Inc, Form S-1/A, Filing Date Jan 29, 2013 |publisher=secdatabase.com |accessdate =Apr 26, 2018}} 18. ^1 {{cite news|url=https://dealbook.nytimes.com/2013/02/01/shares-of-zoetis-surge-on-debut/|title=Shares of Zoetis Surge on Debut|last=J. DE LA MERCED|first=MICHAEL|date=1 February 2013|work=New York Times|accessdate=1 February 2013|location=New York}} 19. ^{{cite web|url=http://edgar.secdatabase.com/1890/119312512240111/filing-main.htm |title=Facebook, Form 424B4, Filing Date May 18, 2012 |publisher=secdatabase.com |accessdate =Apr 27, 2018}} 20. ^{{cite web|url=http://edgar.secdatabase.com/67/119312513027025/filing-main.htm |title=Zoetis, Form S-1/A, Filing Date Jan 29, 2013 |publisher=secdatabase.com |accessdate =Apr 27, 2018}} 21. ^{{cite web|url=http://edgar.secdatabase.com/1559/155528015000240/filing-main.htm |title=Zoetis, Form 8-K, Current Report, Filing Date Nov 2, 2015 |publisher=secdatabase.com |accessdate =Apr 27, 2018}} 22. ^http://www.genengnews.com/gen-news-highlights/zoetis-purchasing-pharmaq-for-765m/81251930/ 23. ^{{cite news |last=Vinluan |first=Frank |date=13 Apr 2017 |title= Zoetis Builds on Biologics Pipeline with $85M Nexvet Acquisition|url=https://www.xconomy.com/new-york/2017/04/13/zoetis-builds-on-biologics-pipeline-with-85m-nexvet-acquisition/ |work= Xconomy|location=New York, NY, USA |access-date=9 Apr 2018 }} 24. ^https://uk.reuters.com/article/uk-abaxis-m-a-zoetis/zoetis-to-buy-veterinary-diagnostics-firm-abaxis-for-1-9-billion-idUKKCN1IH1DR 25. ^[https://animalhealth.pfizer.com/sites/PAHWeb/US/EN/Products/Pages/ProductsLanding.aspx Pfizer Animal Health Products] {{webarchive |url=https://web.archive.org/web/20120722105606/https://animalhealth.pfizer.com/sites/PAHWeb/US/EN/Products/Pages/ProductsLanding.aspx |date=22 July 2012 }} External links
| symbol = ZTS | sec_cik = ZTS | yahoo = ZTS | google = ZTS | bloomberg = ZTS:US }} 10 : Companies based in Morris County, New Jersey|Pharmaceutical companies established in 1952|Companies listed on the New York Stock Exchange|Research and development in the United States|Madison, New Jersey|Pharmaceutical companies based in New Jersey|Veterinary medicine companies|2013 initial public offerings|Corporate spin-offs|1952 establishments in Indiana |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。